|
CTPS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.06399955091786E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.4833000000779E-07 |
| Normal-vs-Stage2 |
1.269740E-02 |
| Normal-vs-Stage3 |
2.437500E-04 |
| Normal-vs-Stage4 |
2.174600E-01 |
| Stage1-vs-Stage2 |
1.539650E-01 |
| Stage1-vs-Stage3 |
7.984200E-01 |
| Stage1-vs-Stage4 |
3.041900E-02 |
| Stage2-vs-Stage3 |
3.047000E-01 |
| Stage2-vs-Stage4 |
3.444000E-01 |
| Stage3-vs-Stage4 |
9.326500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.47009999729164E-08 |
| Normal-vs-AfricanAmerican |
1.425800E-04 |
| Normal-vs-Asian |
3.840800E-01 |
| Caucasian-vs-AfricanAmerican |
8.685400E-01 |
| Caucasian-vs-Asian |
7.028200E-01 |
| AfricanAmerican-vs-Asian |
6.877600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.73909999734434E-08 |
| Normal-vs-Female |
1.82299999995639E-06 |
| Male-vs-Female |
3.320200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.031140E-04 |
| Normal-vs-Extreme_Weight |
2.01679999999316E-05 |
| Normal-vs-Obese |
9.9532999999985E-05 |
| Normal-vs-Extreme_Obese |
7.767900E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.693600E-01 |
| Normal_Weight-vs-Obese |
4.924600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.355400E-01 |
| Extreme_Weight-vs-Obese |
1.415620E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.910000E-01 |
| Obese-vs-Extreme_Obese |
5.658200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.892400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.43340000372072E-08 |
| Normal-vs-Age(61-80Yrs) |
9.21789999996925E-07 |
| Normal-vs-Age(81-100Yrs) |
2.628200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.088600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.107600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.090600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.555600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.706350E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.292600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.73829994842833E-09 |
| Normal-VS-Type2 PRCC |
7.93530000000597E-05 |
| Normal-VS-KIRP CIMP |
5.688400E-02 |
| Normal-VS-Unclassified PRCC |
1.500380E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.435800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.571000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.735800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.403970E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.708400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.727800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.244300E-04 |
| Normal-vs-N1 |
4.880200E-03 |
| Normal-vs-N2 |
2.868000E-01 |
| N0-vs-N1 |
9.200000E-01 |
| N0-vs-N2 |
3.254200E-01 |
| N1-vs-N2 |
3.572400E-01 |
|
|
